Expression of COX-2 and hsp72 in peritoneal macrophages after an acute ochratoxin A treatment in mice

Life Sciences

Volumn 79, Issue 13, 2006, Pages 1242-1247

  Ferrante, Maria Carmela ^a   Bilancione, Marcella ^a   Raso, Giuseppina Mattace ^a   Esposito, Emanuela ^a   Iacono, Anna ^a   Zaccaroni, Annalisa ^b   Meli, Rosaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cyclooxygenase 2; Heat shock protein 72; Lipid peroxidation; Myeloperoxidase activity; Ochratoxin A; Peritoneal macrophage

Indexed keywords

CYCLOOXYGENASE 2; HEAT SHOCK PROTEIN 72; OCHRATOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LYSATE; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CYCLOOXYGENASE 2; DUODENUM; HSP72 HEAT-SHOCK PROTEINS; KIDNEY; LIPID PEROXIDATION; LIVER; MACROPHAGES, PERITONEAL; MALE; MALONDIALDEHYDE; MICE; NEUTROPHILS; OCHRATOXINS; PEROXIDASE;

ANIMALIA; ASPERGILLUS; PENICILLIUM;

EID: 33746889827     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.03.031     Document Type: Article

References (50)

1. Akarasereenont P., Mitchell J.A., Appleton I., Thiemermann C., and Vane J.R. Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells. British Journal of Pharmacology 113 4 (1994) 1522-1528
2. Al-Anati L., Katz N., and Petzinger E. Interference of arachidonic acid and its metabolites with TNF-alpha release by ochratoxin A from rat liver. Toxicology 208 3 (2005) 335-346
3. Alvarez L., Gil A.G., Ezpeleta O., Garcia-Jalon J.A., and Lopez de Cerain A. Immunotoxic effects of ochratoxin A in Wistar rats after oral administration. Food and Chemical Toxicology 42 5 (2004) 825-834
4. Aukema H.M., House J.D., Bankovic-Calic N., and Ogborn M.R. Increased renal fibrosis and expression of renal phosphatidyl-inositol 4-kinase-beta and phospholipase C (gamma 1) proteins in piglets exposed to ochratoxin A. Nephron Physiology 96 1 (2004) P19-P25
5. Baldi A., Losio M.N., Cheli F., Rebucci R., Sangalli L., Fusi E., Bertasi B., Pavoni E., Carli S., and Politis I. Evaluation of the protective effects of alpha-tocopherol and retinol against ochratoxin A cytotoxicity. British Journal of Nutrition 91 4 (2004) 507-512
6. Barišić K., Petrik J., Rumona L., Čepelak I., and Grubišić T.Z. Expression of Hsp 70 in kidney cells exposed to ochratoxin A. Archives of Toxicology 76 4 (2002) 218-226
7. Belmadani A., Tramu G., Betbeder A.M., Steyn P.S., and Creppy E.E. Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain. Archives of Toxicology 72 10 (1998) 656-662
8. Boorman G.A., Hong H.L., Dieter M.P., Hayes H.T., Pohland A.E., Stack M., and Luster M.I. Myelotoxicity and macrophage alteration in mice exposed to ochratoxin A. Toxicology and Applied Pharmacology 72 2 (1984) 304-312
9. Bradley P.P., Priebat D.A., Christensen R.D., and Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. Journal of Investigative Dermatology 78 3 (1982) 206-209
10. Creppy E.E., Kane A., Dirheimer G., Lafarge-Frayssinet C., Mousset S., and Frayssinet C. Genotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen, liver and kidney. Toxicology Letters 28 1 (1985) 29-35
11. Draper H.H., and Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods in Enzymology 186 (1990) 421-431
12. Fantone J.C., and Ward P.A. Role of oxygen-derived free radicals and metabolites in leucocyte-dependent inflammatory reactions. American Journal of Pathology 107 3 (1982) 395-418
13. Gillman I.G., Clark T.N., and Manderville R.A. Oxidation of ochratoxin A by an Fe-porphyrin system: model for enzymatic activation and DNA cleavage. Chemical Research in Toxicology 12 11 (1999) 1066-1076
14. Harvey R.B., Elissalde M.H., Kubena L.F., Weaver E.A., Corrier D.E., and Clement B.A. Immunotoxicity of ochratoxin A to growing gilts. American Journal of Veterinary Research 53 10 (1992) 1966-1970
15. Hoehler D., Marquardt R.R., McIntosh A.R., and Xiao H. Free radical generation as induced by ochratoxin A and its analogs in bacteria (Bacillus brevis). Journal of Biological Chemistry 271 44 (1996) 27388-27394
16. Hoehler D., Marquardt R.R., McIntosh A.R., and Hatch G.M. Induction of free radicals in hepatocytes, mitochondria and microsomes of rats by ochratoxin A and its analogs. Biochimica et Biophysica Acta 1357 2 (1997) 225-233
17. Hong H.H., Jameson C.W., and Boorman G.A. Residual hematopoietic effect in mice exposed to ochratoxin A prior to irradiation. Toxicology 53 1 (1988) 57-67
18. Ianaro A., Ialenti A., Maffia P., Pisano B., and Di Rosa M. Role of cyclopentenone prostaglandins in rat carrageenan pleurisy. FEBS Letters 508 1 (2001) 61-66
19. Jaattela M., Wissing D., Bauer P.A., and Li G.C. Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO Journal 11 10 (1992) 3507-3512
20. Jia Q., and Pestka J.J. Role of cyclooxygenase-2 in deoxynivalenol-induced immunoglobulin a nephropathy. Food and Chemical Toxicology 43 5 (2005) 721-728
21. Kane A., Creppy E.E., Roschenthaler R., and Dirheimer G. Changes in urinary and renal tubular enzymes caused by subchronic administration of ochratoxin A in rats. Toxicology 42 2-3 (1986) 233-243
22. Kanisawa M., Suzuki S., and Moroi K. The mode of action of ochratoxin A in acute enteritis in rats. Journal of Environmental Pathology, Toxicology and Oncology 10 1-2 (1990) 56-63
23. Klahr S., and Morrissey J. Progression of chronic renal disease. American Journal of Kidney Diseases 41 3 suppl 1 (2003) S3-S7
24. Kuiper-Goodman T., and Scott P.M. Risk assessment of the mycotoxin ochratoxin A. Biomedical and Environmental Sciences 2 3 (1989) 179-248
25. Lee S.C., Beery J.T., and Chu F.S. Immunohistochemical fate of ochratoxin A in mice. Toxicology and Applied Pharmacology 72 2 (1984) 218-227
26. Luster M.I., Germolec D.R., Burleson G.R., Jameson C.W., Ackermann M.F., Lamm K.R., and Hayes H.T. Selective immunosuppression in mice of natural killer cell activity by ochratoxin A. Cancer Research 47 9 (1987) 2259-2263
27. Maresca M., Mahfoud R., Pfohl-Leszkowicz A., and Fantini J. The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. Toxicology and Applied Pharmacology 176 1 (2001) 54-63
28. 1 on inducible nitric oxide synthase and cyclooxygenase-2 in LPS-stimulated J774A.1 cells. Life Sciences 67 23 (2000) 2845-2853
29. Mitchell J.A., Belvisi M.G., Akarasereenont P., Robbins R.A., Know O.J., Croxtall J., Barnes P.J., and Vane J.R. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. British Journal of Pharmacology 113 3 (1994) 1008-1014
30. Moon Y., and Pestka J.J. Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases. Toxicological Sciences 69 2 (2002) 373-382
31. Moroi K., Suzuki S., Kuga T., Yamazaki M., and Kanisawa M. Reduction of ochratoxin A toxicity in mice treated with phenylalanine and phenobarbital. Toxicology Letters 25 1 (1985) 1-5
32. Müller G., Kielstein P., Kohler H., Berndt A., and Rosner H. Studies of the influence of ochratoxin A on immune and defense reactions in the mouse model. Mycoses 38 1-2 (1995) 85-91
33. Müller G., Kielstein P., Rosner H., Berndt A., Heller M., and Kohler H. Studies of the influence of ochratoxin A on immune and defence reactions in weaners. Mycoses 42 7-8 (1999) 495-505
34. Müller G., Rosner H., Rohrmann B., Erler W., Geschwend G., Grafe U., Burkert B., Moller U., Diller R., Sachse K., and Kohler H. Effects of the mycotoxin ochratoxin A and some of its metabolites on the human cell line THP-1. Toxicology 184 1 (2003) 69-82
35. National Toxicology Program. Technical report on the toxicology and carcinogenesis studies of ochratoxin A (Case n° 303-47-9). In: Boorman G. (Ed). F 344/N rats (Gavage studies) (1989), US Department of Health and Human services, NIH Publication n° 89-2813, Research Triangle Park, NC
36. Pockley A.G. Heat shock proteins, inflammation, and cardiovascular diseases. Circulation 105 8 (2002) 1012-1017
37. Politis I., Fegeros K., Nitsch S., Schatzmayr G., and Kantas D. Use of Trichosporon mycotoxinivorans to suppress the effects of ochratoxicosis on the immune system of broiler chicks. British Poultry Sciences 46 1 (2005) 58-65
38. Rahimtula A.D., Bereziat J.C., Bussacchini-Griot V., and Bartsch H. Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochemical Pharmacology 37 23 (1988) 4469-4477
39. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.C., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proceedings of the National Academy of Sciences of the United States of America 90 15 (1993) 7240-7244
40. Santoro M.G. Heat shock factors and the control of the stress response. Biochemical Pharmacology 59 1 (2000) 55-63
41. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., and Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proceedings of the National Academy of Sciences of the United States of America 91 25 (1994) 12013-12017
42. Singh G.S., Chauhan H.V., Jha G.J., and Singh K.K. Immunosuppression due to chronic ochratoxicosis in broiler chicks. Journal of Comparative Pathology 103 4 (1990) 399-410
43. Speijers G.J.A., and Van Egmond H.P. Worldwide ochratoxin A levels in food and feeds. In: Creppy E.E., et al. (Ed). Human Ochratoxicosis and its Pathologies vol. 231 (1993), Colloque INSERM/John Libbey Eurotext Ltd, Montrouge 85-100
44. Swierkosz T.A., Mitchell J.A., Warner T.D., Botting R.M., and Vane J.R. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. British Journal of Pharmacology 114 7 (1995) 1335-1342
45. Van Der Merwe K.J., Steyn P.S., Fourie L., Scott D.B., and Theron J.J. Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 205 976 (1965) 1112-1113
46. Van Molle W., Wielockx B., Mahieu T., Takada M., Taniguchi T., Sekikawa K., and Libert C. HSP70 protects against TNF-induced lethal inflammatory shock. Immunity 16 5 (2002) 685-695
47. Vrabcheva T., Petkova-Bocharova T., Grosso F., Nikolov I., Chernozemsky I.N., Castegnaro M., and Dragacci S. Analysis of ochratoxin A in foods consumed by inhabitants from an area with balkan endemic nephropathy: a 1 month follow-up study. Journal of Agricultural and Food Chemistry 52 8 (2004) 2404-2410
48. Wei X., and Sulik K.K. Pathogenesis of craniofacial and body wall malformations induced by ochratoxin A in mice. American Journal of Medical Genetics 47 6 (1993) 862-871
49. Weidenbach A., Schuh K., Failing K., and Petzinger E. Ochratoxin A induced TNF-alpha release from the isolated and blood-free perfused rat liver. Mycotoxin Research 16A (2000) 189-193
50. Zamora R., Bult H., and Herman A.G. The role of prostaglandin E2 and nitric oxide in cell death in J774 murine macrophages. European Journal of Pharmacology 349 2-3 (1998) 307-315